Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study

Circulation

Volumn 101, Issue 2, 2000, Pages 131-136

  Bertrand, Michel E ^a   Esplugas, Enrique ^b   Piessens, Jan ^d   Rasch, Wenche ^c  

^a UNIV LILLE   (France)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c ALTANA PHARMA AG   (Germany)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Angiography; Angioplasty; Contrast media; Stents

Indexed keywords

CONTRAST MEDIUM; IODIXANOL; IOXAGLIC ACID; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EUROPE; FEMALE; GASTROINTESTINAL TOXICITY; HEART DISEASE; HUMAN; HYPERSENSITIVITY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033977684     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.2.131     Document Type: Article

References (31)

1. Esplugas E, Cequier A, Jara F, Mauri J, Soler T, Sala J, Sabate X. Risk of thrombosis during coronary angioplasty with low osmolality contrast media. Am J Cardiol. 1991;68:1020-1024.
2. Lembo NJ, King SB III, Roubin GS, Black AJ, Douglas JS Jr. Effects of nonionic versus ionic contrast media on complications of percutaneous transluminal coronary angioplasty. Am J Cardiol. 1991;67:1046-1050.
3. Piessens JH, Stammen F, Vrolix MC, Glazier JJ, Benit E, De Geest H, Willems JL. Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. Cathet Cardiovasc Diagn. 1993;28:99-105.
4. Grines CL, Schreiber TL, Savas V, Jones DE, Zidar FJ, Gangadharan V, Brodsky M, Levin R, Safian R, Puchrowicz-Ochocki S, Castellani MD, O'Neill WW. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1996;27:1381-1386.
5. Malekianpour M, Bonan R, Lesperance J, Gosselin G, Hudon G, Doucet S, Laurier J, Duval D. Comparison of ionic and nonionic low osmolar contrast media in relation to thrombotic complications of angioplasty in patients with unstable angina. Am Heart J. 1998;135:1067-1075.
6. Gasperetti CM, Feldman MD, Burwell LR, Angello DA, Haugh KH, Owen RM, Powers ER. Influence of contrast media on thrombus formation during coronary angioplasty. J Am Coll Cardiol. 1991;18: 443-450.
7. Husted SE, Kanstrup H. Thrombotic complications in coronary angioplasty: ionic versus non-ionic low-osmolar contrast media. Acta Radiol. 1998;39:340-343.
8. Qureshi NR, den Heijer P, Crijns HJ. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina. Am J Cardiol. 1997;80:700-704.
9. Fareed J, Walenga JM, Saravia GE, Moncada RM. Thrombogenic potential of nonionic contrast media? Radiology. 1990;174:321-325.
10. Ing JJ, Smith DC, Bull BS. Differing mechanisms of clotting inhibition by ionic and nonionic contrast agents. Radiology. 1989;172:345-348.
11. Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation. 1993;88: 2035-2044.
12. Corot C, Chronos N, Sabattier V. In vitro comparison of the effects of contrast media on coagulation and platelet activation. Blood Coagul Fibrinolysis. 1996;7:602-608.
13. Brass O, Belleville J, Sabattier V, Corot C. Effect of ioxaglate-an ionic low osmolar contrast medium on fibrin polymerization in vitro. Blood Coagul Fibrinolysis. 1993;4:689-697.
14. Aguejouf O, Doutremepuich F, Azougagh Oualane F, Doutremepuich C. Thrombogenicity of ionic and nonionic contrast media tested in a laser induced rat thrombosis model. Thromb Res. 1995;77:259-269.
15. Hardeman MR, Konijnenberg A, Sturk A, Reekers JA. Activation of platelets by low-osmolar contrast media: differential effects of ionic and nonionic agents. Radiology. 1994;192:563-566.
16. Arora R, Khandelwal M, Gopal A. In vivo effects of nonionic and ionic contrast media on α-thromboglobulin and fibrinopeptide levels. J Am Coll Cardiol. 1991;17:1533-1536.
17. Albanese JR, Venditto JA, Patel GC, Ambrose JA. Effects of ionic and nonionic contrast media on in vitro and in vivo platelet activation. Am J Cardiol. 1995;76:1059-1063.
18. Mamon JF, Hoppensteadt D, Fareed J, Moncada R. Biochemical evidence for a relative lack of inhibition of thrombin formation by nonionic contrast media. Radiology. 1991;179:399-402.
19. Stormorken H, Sakariassen KS. In vitro platelet degranulation by contrast media: clinical relevance? Circulation. 1994;90:1580-1581.
20. Eloy R, Corot C, Belleville J. Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility. Clin Mater. 1991;7:89-197.
21. Barstad RM, Kierulf P, Sakariassen KS. Collagen induced thrombus formation at the apex of eccentric stenoses: a time course study with non-anticoagulated human blood. Thromb Haemost. 1996;75:685-692.
22. Hathcock J, Sakariassen K, Turitto V. Tissue factor activity in rat vascular smooth muscle cells exposed to ionic and non-ionic contrast media. Thromb Haemost. 1997;78:828.
23. Sakariassen KS, Barstad RM, Hamers MJ, Stormorken H. Iohexol, platelet activation, and thrombosis, I: iohexol-induced platelet secretion does not affect thrombus formation in native blood. Acta Radiol 1998;39: 349-354.
24. Sakariassen KS, Buchmann M, Hamers MJ, Stormorken H. lohexol, platelet activation, and thrombosis, II: iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin. Acta Radiol. 1998;39:355-361.
25. Schräder R, Esch I, Ensslen R, Fach WA, Merle H, Scherer D, Sievert H, Spies HF, Zeplin HE. A randomized trial comparing the impact of a nonionic (iomeprol) versus an ionic (ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J Am Coll Cardiol 1999;33:395-402.
26. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration-Radiology. 1997;203:605-610.
27. Hill JA, Winniford M, Cohen MB, Van Fossen DB, Murphy MJ, Halpern EF, Ludbrook PA, Wexler L, Rudnick MR, Goldfarb S. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography: the lohexol Cooperative Study. Am J Cardiol. 1993;72:770-775.
28. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med. 1992;326:431-436.
29. Steinberg EP, Moore RD, Powe NR, Gopalan R, Davidoff AJ, Litt M, Graziano S, Brinker JA. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med. 1992;326:425-430.
30. Hellige G, Vogel B, Tebbe U, Kreuzer H. Contrast media in cardiology: report of a randomized, double-blind multicenter comparative study of the side effects of ionic and non-ionic roentgen contrast media. Z Kardiol. 1992;81:290-292.
31. Gertz EW, Wisneski JA, Miller R, Knudtson M, Robb J, Dragatakis L, Browne KF Jr, Vetrovec G, Smith SC Jr. Adverse reactions of low osmolality contrast media during cardiac angiography: a prospective randomized multicenter study. J Am Coll Cardiol. 1992;19:899-906.